diabetes

Takeda Diabetes Drug Succeeding Actos Wins FDA Approval

Takeda Diabetes Drug Succeeding Actos Wins FDA Approval

Bloomberg

Glaxo Plaintiff Lawyers Settle Dispute Over $143 Million

Glaxo Plaintiff Lawyers Settle Dispute Over $143 Million

Bloomberg

Big Pharma Diabetes Face-Off

Big Pharma Diabetes Face-Off

The Motley Fool

UPDATE: GI Dynamics launches U.S. EndoBarrier diabetes trial

UPDATE: GI Dynamics launches U.S. EndoBarrier diabetes trial

Mass Device

GSK files for U.S. approval of new diabetes drug

GSK files for U.S. approval of new diabetes drug

Reuters

Can J&J Get Its Diabetes Drug Past the Safety-First FDA?

Can J&J Get Its Diabetes Drug Past the Safety-First FDA?

Motley Fool

Can J&J Get Its Diabetes Drug Past the Safety-First FDA?

Can J&J Get Its Diabetes Drug Past the Safety-First FDA?

Motley Fool

FDA Panel Backs Novel Diabetes Pill From J&J

FDA Panel Backs Novel Diabetes Pill From J&J

Motley Fool

J&J Diabetes Drug Faces Questions at FDA Advisory Panel

J&J Diabetes Drug Faces Questions at FDA Advisory Panel

Motley Fool

J&J Diabetes Pill May Have Heart Risks, FDA Staff Says

J&J Diabetes Pill May Have Heart Risks, FDA Staff Says

Bloomberg